DENISE ADAMS: Open Payments
NPI 1164761748 · EDDYVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 34 payments from 13 companies in 2025. Trend: 2023 $774 · 2024 $544 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $157 |
| Otsuka America Pharmaceutical, Inc. | 5 | $96 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| Phathom Pharmaceuticals, Inc. | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 1 | $53 |
| ABBVIE INC. | 2 | $36 |
| Lilly USA, LLC | 2 | $34 |
| PFIZER INC. | 2 | $34 |
| Boston Scientific Corporation | 1 | $34 |
| Vanda Pharmaceuticals Inc. | 2 | $33 |
Products named: REXULTI, Wegovy, VOQUEZNA, AIRSUPRA, LEQVIO, MOUNJARO, WATCHMAN Access System, ENTRESTO.
Industry payments across KY — which companies pay providers there.
